logo

For the Inventor, By the Inventor

Concord, CA, United States of America

Cerus Corporation


USPTO Granted Patents = 76

% Expired Patents = 17.1



Trademarks = 1

Forward Citations = 1,644

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Susan Wollowitz (25 out of 36 patents)

silverMedal Stephen T Isaacs (22 out of 39 patents)

bronzeMedal Henry Rapoport (17 out of 48 patents)

4.  George D Cimino (16 out of 34 patents)

5.  Aileen Nerio (16 out of 18 patents)

6.  Hans Peter Spielmann (15 out of 22 patents)

7.  David N Cook (10 out of 21 patents)

8.  Adonis Stassinopoulos (9 out of 13 patents)

9.  Daniel Church (9 out of 10 patents)

10.  Laurence Corash (8 out of 12 patents)

11.  Derek J Hei (8 out of 12 patents)

12.  Lloyd Ison (7 out of 7 patents)

13.  Anna Erickson (6 out of 6 patents)

14.  Naheed Mufti (6 out of 6 patents)

15.  John E Hearst (6 out of 22 patents)


Core Competencies:
Biological Fluids
Pathogen Inactivation
Platelet Compositions
Photodecontamination
Cryoprecipitate
Light Processing
Synthetic Media
Psoralens
Blood Products
Compounds
Fluid Treatment
Quenching Methods

76 patents:

1. 12741042 - Modular light device for a biological fluid treatment system (2026-09-22),
2. 12728186 - Methods and kits for preparing pathogen-inactivated whole blood (2026-09-08),
3. 12558442 - Biological fluid treatment systems (2026-02-24),
4. 12514876 - Cryoprecipitate compositions and methods of preparation thereof (2026-01-06),
5. 12343436 - System and methods for implementing a biological fluid treatment device (2025-07-01),
6. 12282015 - Systems and methods for testing and screening using compound bound substrates (2025-04-21),
7. 12214092 - Systems and methods for treating biological fluids (2025-02-04),
8. D1042788 - Illuminator device (2024-09-17),
9. 12064537 - Kits and methods for preparing pathogen-inactivated platelet compositions (2024-08-20),
10. D1035969 - Illuminator device (2024-07-16),
11. 12011510 - Biological fluid treatment systems (2024-06-18),
12. 11883544 - System and methods for implementing a biological fluid treatment device (2024-01-30),
13. 11554185 - Systems and methods for treating biological fluids (2023-01-17),
14. 11235090 - Kits and methods for preparing pathogen-inactivated platelet compositions (2022-02-01),
15. 11096963 - Cryoprecipitate compositions and methods of preparation thereof (2021-08-24),
Cerus Corporation, based in Concord, California, specializes in the development and manufacturing of innovative technologies for biological fluid treatment. The company focuses on pathogen inactivation processes to enhance the safety of blood products, including platelets and cryoprecipitate. Cerus employs advanced techniques such as photodecontamination and light processing, utilizing synthetic media and psoralens to ensure the efficacy and safety of biological fluids. Its commitment to improving transfusion medicine positions Cerus as a leader in the field.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Cerus Corporation
76 Patents

#1 in Concord, CA

#1,131 in California

#4,837 in US

#9,873 in the World

Concord, CA (US)
Concord, CA, United States of America

Cerus Corporation

Forward Citations = 1,644

61 inventors:

goldMedal Susan Wollowitz (25 out of 36 patents)

silverMedal Stephen T Isaacs (22 out of 39 patents)

bronzeMedal Henry Rapoport (17 out of 48 patents)

4.  George D Cimino (16 out of 34 patents)

5.  Aileen Nerio (16 out of 18 patents)

Please report any incorrect information to [email protected]
Loading…